Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2008
12/03/2008EP1996577A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
12/03/2008EP1996559A1 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
12/03/2008EP1996551A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them.
12/03/2008EP1996183A1 Method of treatment or prophylaxis inflammatory pain
12/03/2008EP1996179A2 Compositions for disorders associated with metachromatic cell activation
12/03/2008EP1778633B1 Indoles useful in the treatment of inflammation
12/03/2008EP1776340B1 N-(1h-indolyl)-h-indole-2-carb0xamide derivatives, their preparation and their therapeutic use
12/03/2008EP1538980A4 Devices and methodologies useful in body aesthetics
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008EP1511499B1 Immunomodulatory compounds and methods of use thereof
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol
12/03/2008EP1470144B1 Oligonucleotides comprising alternating segments and uses thereof
12/03/2008EP1419129B1 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
12/03/2008EP1377540B1 Inhibitors of integrin alpha-v-beta-6
12/03/2008EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
12/03/2008EP1297828B1 Oral formulations for localized colonic release and the method of preparation thereof
12/03/2008EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors
12/03/2008EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof
12/03/2008CN201157562Y Warm-application muscles and bones rheumatism emplastrum
12/03/2008CN201157442Y Electric heating treatment ache plaster
12/03/2008CN101316930A T-cell adhesion molecule and antibody directed against the molecule
12/03/2008CN101316834A 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors
12/03/2008CN101316833A Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
12/03/2008CN101316822A 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316821A Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101314029A Acetylsalicylic peptide and preparation method thereof
12/03/2008CN101314025A Anti-inflammation febrifuge medicament and preparation method thereof
12/03/2008CN101314022A Externally used drug for treating bone joint diseases and preparation method thereof
12/03/2008CN101314016A Compound andrographis paniculata injection for treating pig hyperpyrexia and preparation method thereof
12/03/2008CN101313999A Pellet composition for promoting the reunion of fractured bones
12/03/2008CN101313997A Sore plaster composition of traditional Chinese medicine nonometer new technique
12/03/2008CN101313966A Medicament for treating asphyxia
12/03/2008CN101313949A Multifunctional compound berberine tablet
12/03/2008CN101313944A Herbal pain penetrating fluid
12/03/2008CN101313934A Navel treatment traditional Chinese medicine preparation for removing icterus
12/03/2008CN101313923A Polyphenol extracted from pistacia chinensis cake and extracting method thereof
12/03/2008CN101313913A Hyaluronate lyase restrainer
12/03/2008CN101313891A Palmatine injection and preparation method thereof
12/03/2008CN101313886A Health care Chinese traditional liquid medicine for bathing foot
12/03/2008CN100439370C Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100439339C 2-pyridone derivatives as netrophil elastase inhibitors and their use.
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100439314C Non-steroid anti-inflammatory agent felbinac preparation method
12/03/2008CN100438910C Preventives/remedies for liver diseases
12/03/2008CN100438909C 化合物 Compound
12/03/2008CN100438886C Chrysanthem pain relieving medicinal preparation
12/03/2008CN100438877C (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
12/03/2008CN100438873C Application of tetrodotoxin as analgesic tolerance inhibitor in preparation of compound pain relieving preparation
12/03/2008CN100438869C Indometacin preparation for external use
12/03/2008CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum
12/03/2008CN100438859C Transdermal therapeutic system (TTS) with fentanyl as active ingredient
12/03/2008CN100438856C Yimaikang dispersion tablet and its preparing method
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents
12/02/2008US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459455 Pyrimidine compounds
12/02/2008US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety.
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459283 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008CA2394230C Novel stromelysin inhibitors
12/02/2008CA2381203C Formulations for treating or preventing mucositis
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2340224C Nimesulide containing topical pharmaceutical compositions
12/02/2008CA2140220C Inhibition of infection-stimulated oral tissue destruction by .beta.(1,3)-glucan
11/2008
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008144360A1 Novel compounds as cannabinoid receptor ligands
11/27/2008WO2008144019A2 Suppression of allergic inflammation by ascaris heme-binding protein (hbp)
11/27/2008WO2008142550A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008WO2008142319A2 Peptide analogues of melanocortin receptors
11/27/2008WO2008141511A1 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF
11/27/2008WO2008121742A3 Inhibitors of bruton's tyrosine kinase
11/27/2008WO2008109532A3 Nucleic acid compounds for inhibiting fas gene expression and uses thereof
11/27/2008WO2008101693A3 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds
11/27/2008WO2008101692A3 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline
11/27/2008WO2008061647A8 Use of a compound as vegf inhibitor
11/27/2008WO2008058210B1 Local administration of gallium compositions to treat pain
11/27/2008WO2007131253A3 Use of combination preparations comprising antifungal agents
11/27/2008US20080293962 Novel compounds of the N-acylamino amide family compositions comprising them and uses thereof
11/27/2008US20080293939 Quinazolinone derivatives useful as anti-hyperalgesic agents
11/27/2008US20080293819 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors
11/27/2008US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof
11/27/2008US20080293794 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
11/27/2008US20080293792 (R)-2-(9-(1H-imidazol-1-yl)nonyl)-2,5,7,8-tetramethylchroman-6-ol, capable of inhibiting tocopherol-omega-hydroxylase, responsible for the metabolism of tocopherol and tocotrienol compounds of vitamin E, and thus increase the amount and prolong the bioavailability of these compounds in plasma and tissue
11/27/2008US20080293781 Salicylic Acid Derivatives
11/27/2008US20080293765 Alkylsulphonamide Quinolines
11/27/2008US20080293758 Combination of a Steroid Sulfatase Inhibitor and an Ascomycin
11/27/2008US20080293749 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293746 Combinations comprising pregabalin
11/27/2008US20080293732 Substituted pyrazoles
11/27/2008US20080293717 Aryl sulfonamides
11/27/2008US20080293714 Tec Kinase Inhibitors
11/27/2008US20080293703 Topical Preparation and Method for Transdermal Delivery and Localization of Therapeutic Agents
11/27/2008US20080293700 Compositions and Methods Relating to Novel Compounds and Targets Thereof
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells